COVID-19

Borgess Hospital part of trial to use blood plasma to treat coronavirus

The trial will see if blood from previously infected people can be used to treat those with new infections.

Ascension Borgess Hospital in Kalamazoo is part of a national trial seeking a treatment for COVID-19 infections.

The trial will take blood plasma from people who have successfully recovered from a COVID-19 infection and see if antibodies in the blood can treat people with new infections, according to a report by WMUK.

WMUK logo

NowKalamazoo is supported by WMUK Public Media. Offering news and conversation from NPR at 102.1FM and classical music & local arts at 89.9FM. Celebrating 70 years of public radio excellence!

Listen on the radio dial or smart speaker, stream online at wmuk.org, or on the WMUK app for mobile devices.

The antibodies can “teach” a person’s own immune system to combat the disease.

“This has been done many times before with other coronaviruses with, frankly, somewhat mixed results,” said Borgess Chief Medical Officer Dr. Thomas Rohs to WMUK.

You can hear the full story here.